Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chamberlin

Showing results (971-980 of 1,103) with videos related to

Pageof 111
Sort By:
Neuropharmacology|September 27, 2005
The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3C Sean Esslinger, Shailesh Agarwal, John Gerdes, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
The New Phytologist|September 22, 2023
Parallel tuning of semi-dwarfism via differential splicing of Brachytic1 in commercial maize and smallholder sorghumShuping Jiao, Sujan Mamidi, Mark A Chamberlin, et al.
Contemporary Clinical Trials|April 20, 2026
The medication affordability, accessibility, and availability in care transitions (med AAAction) study: Design and methods for a pharmacy-led trial implemented in low-income populationsYamini Mallisetty, Rushin Shah, Thomas Kerby, et al.
Rand Health Quarterly|August 8, 2018
Evaluation of the Mental Health Services Act in Los Angeles County: Implementation and Outcomes for Key ProgramsJ Scott Ashwood, Sheryl H Kataoka, Nicole K Eberhart, et al.
Suicide & Life-Threatening Behavior|September 1, 2023
Reconnecting to Internal Sensations and Experiences (RISE): An online, multi-session intervention improves interoceptive sensibility for military personnelApril R Smith, Tracy K Witte, Wendy Troop-Gordon, et al.
G3 (Bethesda, Md.)|September 5, 2020
Genotypic Characterization of the U.S. Peanut Core CollectionPaul I Otyama, Roshan Kulkarni, Kelly Chamberlin, et al.
Human Molecular Genetics|January 5, 2019
Mutations in MAP3K1 that cause 46,XY disorders of sex development disrupt distinct structural domains in the proteinAdam Chamberlin, Robert Huether, Aline Z Machado, et al.
Kidney International|March 11, 2011
Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across speciesMina Patel-Chamberlin, Ying Wang, Bancha Satirapoj, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
Pageof 111

Showing results (971-980 of 1,103) with videos related to

Sort By:
Pageof 111
Neuropharmacology|September 27, 2005
The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3C Sean Esslinger, Shailesh Agarwal, John Gerdes, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
The New Phytologist|September 22, 2023
Parallel tuning of semi-dwarfism via differential splicing of Brachytic1 in commercial maize and smallholder sorghumShuping Jiao, Sujan Mamidi, Mark A Chamberlin, et al.
Contemporary Clinical Trials|April 20, 2026
The medication affordability, accessibility, and availability in care transitions (med AAAction) study: Design and methods for a pharmacy-led trial implemented in low-income populationsYamini Mallisetty, Rushin Shah, Thomas Kerby, et al.
Rand Health Quarterly|August 8, 2018
Evaluation of the Mental Health Services Act in Los Angeles County: Implementation and Outcomes for Key ProgramsJ Scott Ashwood, Sheryl H Kataoka, Nicole K Eberhart, et al.
Suicide & Life-Threatening Behavior|September 1, 2023
Reconnecting to Internal Sensations and Experiences (RISE): An online, multi-session intervention improves interoceptive sensibility for military personnelApril R Smith, Tracy K Witte, Wendy Troop-Gordon, et al.
G3 (Bethesda, Md.)|September 5, 2020
Genotypic Characterization of the U.S. Peanut Core CollectionPaul I Otyama, Roshan Kulkarni, Kelly Chamberlin, et al.
Human Molecular Genetics|January 5, 2019
Mutations in MAP3K1 that cause 46,XY disorders of sex development disrupt distinct structural domains in the proteinAdam Chamberlin, Robert Huether, Aline Z Machado, et al.
Kidney International|March 11, 2011
Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across speciesMina Patel-Chamberlin, Ying Wang, Bancha Satirapoj, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
Pageof 111